Microarray-Based Biomarker Discovery

Abstract

Microarray technology has revolutionized biomarker discovery by enabling the simultaneous analysis of thousands of genes across biological samples. The identification of differential gene expression patterns associated with disease states, the validation of candidate biomarkers through rigorous bioinformatics and statistical analyses, and their translation into clinical diagnostics and therapeutic interventions. The integration of microarray data with other omics technologies enhances the specificity and predictive power of biomarkers, facilitating precision medicine approaches tailored to individual patient profiles. Future directions focus on enhancing sensitivity, reproducibility, and clinical utility, thereby accelerating the discovery and implementation of robust biomarkers for improved patient outcomes.

How to cite this article:
Tripathi D. Microarray-Based Biomarker
Discovery. Rec Trends Pharm Tech Ind 2024
6(1): 17-21.